miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

Abstract
No abstract available
Funding Information
  • European Regional Development Fund
  • Centro 2020 Regional Operational Programme (CENTRO-01-0145-FEDER-000008: BrainHealth 2020)
  • COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation
  • FCT (POCI-01-0145-FEDER-007440, UID/NEU/04539/2013)
  • FCT Investigator Programme (IF/00694/2013)
  • Marie Curie Carrier Integration Grant (PCIG13-GA-2013-618525)
  • HEALTHYAGING 2020 (CENTRO-01-0145-FEDER-000012)
  • Bial Foundation (264/16)
  • FCT (PTDC/BIM-MEC/0651/2012, SFRH/BPD/120611/2016, SFRH/BPD/108312/2015)